Host Chitinase 3-like-1 is a Universal Therapeutic Target for SARS-CoV-2 Viral Variants in COVID 19.
bioRxiv. 2022 Feb 26:2022.01.21.477274. doi: 10.1101/2022.01.21.477274. Preprint.
bioRxiv. 2022.
PMID: 35118470
Free PMC article.
Updated.